Watson PH - Search Results

1

Estrogen receptor variants and mutations.

Murphy LC, Dotzlaw H, Leygue E, Douglas D, Coutts A, Watson PH. Murphy LC, et al. Among authors: watson ph. J Steroid Biochem Mol Biol. 1997 Aug;62(5-6):363-72. doi: 10.1016/s0960-0760(97)00084-8. J Steroid Biochem Mol Biol. 1997. PMID: 9449239 Review.

2

Relationship between mammaglobin expression and estrogen receptor status in breast tumors.

Guan XF, Hamedani MK, Adeyinka A, Walker C, Kemp A, Murphy LC, Watson PH, Leygue E. Guan XF, et al. Among authors: watson ph. Endocrine. 2003 Aug;21(3):245-50. doi: 10.1385/ENDO:21:3:245. Endocrine. 2003. PMID: 14515009

3

Is oestrogen receptor-beta a predictor of endocrine therapy responsiveness in human breast cancer?

Murphy LC, Watson PH. Murphy LC, et al. Among authors: watson ph. Endocr Relat Cancer. 2006 Jun;13(2):327-34. doi: 10.1677/erc.1.01141. Endocr Relat Cancer. 2006. PMID: 16728566 Review.

4

Estrogen receptor alpha negative breast cancer patients: estrogen receptor beta as a therapeutic target.

Skliris GP, Leygue E, Watson PH, Murphy LC. Skliris GP, et al. Among authors: watson ph. J Steroid Biochem Mol Biol. 2008 Mar;109(1-2):1-10. doi: 10.1016/j.jsbmb.2007.12.010. Epub 2007 Dec 8. J Steroid Biochem Mol Biol. 2008. PMID: 18243688 Review.

5

The relevance of phosphorylated forms of estrogen receptor in human breast cancer in vivo.

Murphy LC, Skliris GP, Rowan BG, Al-Dhaheri M, Williams C, Penner C, Troup S, Begic S, Parisien M, Watson PH. Murphy LC, et al. Among authors: watson ph. J Steroid Biochem Mol Biol. 2009 Mar;114(1-2):90-5. doi: 10.1016/j.jsbmb.2009.01.017. Epub 2009 Feb 6. J Steroid Biochem Mol Biol. 2009. PMID: 19429437 Review.

6

Steroid Receptor RNA Activator Protein (SRAP): a potential new prognostic marker for estrogen receptor-positive/node-negative/younger breast cancer patients.

Yan Y, Skliris GP, Penner C, Chooniedass-Kothari S, Cooper C, Nugent Z, Blanchard A, Watson PH, Myal Y, Murphy LC, Leygue E. Yan Y, et al. Among authors: watson ph. Breast Cancer Res. 2009;11(5):R67. doi: 10.1186/bcr2359. Breast Cancer Res. 2009. PMID: 19740422 Free PMC article.

7

Clinical significance of estrogen receptor phosphorylation.

Murphy LC, Seekallu SV, Watson PH. Murphy LC, et al. Among authors: watson ph. Endocr Relat Cancer. 2011 Jan 19;18(1):R1-14. doi: 10.1677/ERC-10-0070. Print 2011 Feb. Endocr Relat Cancer. 2011. PMID: 21149515 Review.

8

Triple primer polymerase chain reaction. A new way to quantify truncated mRNA expression.

Leygue E, Murphy L, Kuttenn F, Watson P. Leygue E, et al. Am J Pathol. 1996 Apr;148(4):1097-103. Am J Pathol. 1996. PMID: 8644852 Free PMC article.

9

The pathophysiological role of estrogen receptor variants in human breast cancer.

Murphy LC, Dotzlaw H, Leygue E, Coutts A, Watson P. Murphy LC, et al. J Steroid Biochem Mol Biol. 1998 Apr;65(1-6):175-80. doi: 10.1016/s0960-0760(98)00012-0. J Steroid Biochem Mol Biol. 1998. PMID: 9699871 Review.

10

The human orphan receptor PXR messenger RNA is expressed in both normal and neoplastic breast tissue.

Dotzlaw H, Leygue E, Watson P, Murphy LC. Dotzlaw H, et al. Clin Cancer Res. 1999 Aug;5(8):2103-7. Clin Cancer Res. 1999. PMID: 10473093

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

260 results

Search Page

Filters